Headline News about Kempharm Inc
![](https://cdn.benzinga.com/files/images/story/2022/11/17/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29750.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/28/aapharma_9.png?width=1200&height=800&fit=crop)
KemPharm's Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder
September 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_776.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_6101.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/image38.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26666.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
September 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3919.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2.jpg)
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2022/08/17/image-apple.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6509.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_3039.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/adam-niescioruk-hwzrjss8gwi-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/28/all_access_imag.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/25/premkt_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_5580.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3163.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3172.png)
![](https://cdn.benzinga.com/files/images/story/2012/biotech_6.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_82.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2676.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2295.jpeg)
![](https://g.foolcdn.com/editorial/images/631189/red-line-falling-100-bill.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_354.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884775_1920_75.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_266.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.